Morgan Stanley cuts XP Inc. stock rating on Brazil outlook concerns

Morgan Stanley downgraded XP Inc. (NASDAQ:XP) to Equalweight, cutting its price target to $19.00 from $23.00. Analyst Jorge Kuri cited Brazil's post-election outlook as undermining the lower-rates thesis. The stock has fallen 45% in a week, trading at $16.09. Morgan Stanley also downgraded B3 (B3SA3.SA) to Equalweight. XP's Q2 2026 earnings beat estimates, with adjusted EPS of $2.67 and revenue of $4.88 billion, but the stock declined due to investor caution.

Original reporting
Published Oct 29, 2026, 8:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$XP
Bearish
high confidence
Mentioned
$XP
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$XPBearishMed
01

Why it matters

The downgrade could trigger short‑selling and reduce inflows into XP and B3, affecting exposure to Brazilian capital markets.

02

Market read

Analyst downgrade adds fresh negative catalyst for XP and B3, likely prompting price declines.

03

What to watch

Potential resilience in XP's earnings despite macro headwinds and its recent earnings beat.

Relevance 7/10Novelty 7/10Timing: today

Background

Morgan Stanley's rating change follows Brazil's presidential runoff and concerns over fiscal policy continuity.

Company-level read

Ticker impact

$XPBearishHigh confidence
Context

Morgan Stanley downgraded XP Inc. to Equalweight and cut its price target to $19, citing Brazil's post‑election outlook.

Expected impact

likely downside as investors price in reduced earnings visibility and higher cost of capital

Evidence & confidence

The downgrade is a fresh, material change to the stock's valuation outlook.

Market effects

Highlights heightened risk perception for Brazil‑focused financial services.

May weigh on broader Brazil equity sentiment amid post‑election uncertainty.

Limited to investors with exposure to emerging‑market financial stocks.

Counterpoint

Some investors may view the downgrade as over‑reacting to political risk, seeing upside potential if Brazil stabilises.

Key entities

  • Morgan Stanley

    Equity research firm issuing the downgrade.

  • Jorge Kuri

    Morgan Stanley analyst covering XP.

Related articles

$XPHigh

Why is Xp stock plummeting 45% today?

Xp Inc. stock dropped 45.3% in pre-market trading to $16.63, driven by corporate governance concerns and a worsening macroeconomic environment. The decline follows leadership changes and a reduction in stake by institutional investor Assenagon. The stock had previously gained significantly year-to-date, reaching a 52-week high of $32.73. The broader financial sector also faced selling pressure due to rising oil prices and inflation fears.

$XPMed

Morgan Stanley Upgrades Brazil Stocks to Buy

Morgan Stanley upgraded Brazilian stocks to overweight, citing potential 15-20% gains by 2026. The bank favors domestic-focused companies like B3, XP, and Nubank. Foreign investors injected R$10.06B into Brazilian stocks on Monday, the largest daily inflow of 2026.